Effectiveness of intensification therapy in patients with type 2 diabetes who used basal insulin only

被引：0
|
作者：
Norrelund, H. [1 ]
Baggesen, L. M. [1 ]
Sogaard, M. [1 ]
Pedersen, L. [1 ]
Buhl, E. S. [2 ]
Haase, C. L. [2 ]
Johnsen, S. P. [1 ]
Thomsen, R. W. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark
[2] Novo Nordisk Scandinavia AB, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
153
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [31] Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
    Juurinen, L.
    Tiikkainen, M.
    Saltevo, J.
    Nikkila, K.
    Lanki, H.
    Leppavuori, E.
    Kock, T.
    Teikari-Myyra, T.
    Kauppinen-Makelin, R.
    Kotronen, A.
    Yki-Jarvinen, H.
    DIABETIC MEDICINE, 2009, 26 (04) : 409 - 415
  • [32] TYPE 2 DIABETES SIMULATOR FOR TESTING BASAL INSULIN THERAPY IN INSULIN-NAIVE PATIENTS
    Visentin, R.
    Schiavon, M.
    Riz, M.
    Goebel, B.
    Klabunde, T.
    Dalla Man, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A69 - A70
  • [33] Stepwise Intensification of Prandial Insulin Versus Basal-Bolus Insulin Therapy in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Raccah, Denis
    Haak, Thomas
    Huet, Dominique
    Monnier, Louis
    Penfornis, Alfred
    Robertson, Douglas
    Labard, Pascale
    Soler Ramon, Juan
    DIABETES, 2010, 59 : A151 - A151
  • [34] The Effectiveness of Basal Plus Compared with Premixed Insulin in Insulin-Naive Type 2 Diabetes Patients
    Raghavan, Arun
    Nanditha, Arun
    Satheesh, Krishnamoorthy
    Snehalatha, Chamukuttan
    Seeli, Abraham Catherin
    Simon, Mary
    Susairaj, Priscilla
    Ramachandran, Ambady
    DIABETES, 2019, 68
  • [35] Gradual Intensification of Premixed Insulin Lispro Therapy vs. Basal plus /- Mealtime Insulin in Patients With Type 2 Diabetes Eating Light Breakfasts
    Woo, Vincent
    Giugliano, Dario
    Tracz, Mariusz
    Mistodie, Cristina
    Calle-Pascual, Alfonso L.
    Duarte, Rui
    Sari, Ramazan
    Jilet-Covici, Alina O.
    Deinhard, Juergen
    Wille, Simone
    Kiljanski, Jacek
    DIABETES, 2012, 61 : A601 - A601
  • [36] THE COSTS OF INTENSIFICATION FROM BASAL INSULIN TO BASAL-BOLUS IN TYPE 2 DIABETES: A SURVEY OF PHYSICIANS
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [37] Update on Basal Insulin Therapy for Type 2 Diabetes Mellitus
    Patel, Hansita B.
    Witte, Amy P.
    US PHARMACIST, 2021, 46 (11) : 44 - 50
  • [38] Optimum management of type 2 diabetes - timely introduction, optimization and intensification of basal insulin
    Dailey, G.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 5 - 13
  • [39] USE OF CGM WITH PEOPLE WITH DIABETES TYPE 2 TREATED WITH BASAL INSULIN ONLY
    Leelarathna, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A2 - A2
  • [40] Contribution of glimepiride to basal-prandial insulin therapy in patients with type 2 diabetes
    Yokoyama, Hiroki
    Sone, Hirohito
    Yamada, Daishiro
    Honjo, Jun
    Haneda, Masakazu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 91 (02) : 148 - 153
12345